Method for determining treatments using patient-specific lung models and computer methods

Details for Australian Patent Application No. 2010251912 (hide)

Owner FluidDA Respi

Inventors De Backer, Jan

Agent Griffith Hack

Pub. Number AU-A-2010251912

PCT Pub. Number WO2010/136528

Priority 61/182,493 29.05.09 US; 09161455.2 29.05.09 EP

Filing date 27 May 2010

Wipo publication date 2 December 2010

International Classifications

A61M 16/00 (2006.01) Devices for influencing the respiratory system of patients by gas treatment, e.g. mouth-to-mouth respiration

A61B 5/08 (2006.01) Measuring for diagnostic purposes - Measuring devices for evaluating the respiratory organs

A61B 6/00 (2006.01) Apparatus for radiation diagnosis, e.g. combined with radiation therapy equipment

G06F 19/00 (2006.01) Digital computing or data processing equipment or methods, specially adapted for specific applications

Event Publications

17 November 2011 PCT application entered the National Phase

  PCT publication WO2010/136528 Priority application(s): WO2010/136528

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2010251930-3-alkyl-5-fluoroindole derivatives as myeloperoxidase inhibitors

2010251910-Resolution of (plus or minus)-methyl phenyl[4-[4-[[[4'-(trifluoromethyl)-2-biph enylyl] carbonyl]amino]phenyl]-1-piperidinyl]acetat e